EBS - Emergent Biosolutions, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Emergent Biosolutions, Inc.
Emergent BioSolutions Inc is a biotechnology company operating in two divisions: biodefense and biosciences. The company focuses on countermeasures that address public health threats around hematology and oncology therapeutics.
IPO Date: December 1, 2006
Sector: Healthcare
Industry: Biotech
Related Tickers:
AMGN GILD VRTX REGN MRNA ARGX ONC IQV RVMD BIIB
Market Cap: $302.84M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.63 | 2.57%
Avg Daily Range (30 D): $0.28 | 4.25%
Avg Daily Range (90 D): $0.22 | 3.38%
Institutional Daily Volume
Avg Daily Volume: .56M
Avg Daily Volume (30 D): .96M
Avg Daily Volume (90 D): .93M
Trade Size
Avg Trade Size (Sh.): 107
Avg Trade Size (Sh.) (30 D): 92
Avg Trade Size (Sh.) (90 D): 86
Institutional Trades
Total Institutional Trades: 5,669
Avg Institutional Trade: $2.3M
Avg Institutional Trade (30 D): $.85M
Avg Institutional Trade (90 D): $.96M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.02M
Avg Closing Trade (30 D): $.86M
Avg Closing Trade (90 D): $.96M
Avg Closing Volume: 111.21K
 
News
Nov 3, 2026 @ 11:42 AM
Emergent BioSolutions: 3 Key Takeaways for Long-Te...
Source: The Motley Fool Team
Oct 27, 2026 @ 10:10 AM
Swedish Orphan Biovitrum (BIOVF) Tops Q3 Earnings ...
Source: Zacks.Com
Oct 6, 2026 @ 8:07 AM
Emergent Biosolutions (EBS) Soars 14.4%: Is Furthe...
Source: Zacks.Com
Sep 23, 2026 @ 12:46 AM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: Pomerantz Llp
Sep 10, 2026 @ 12:30 AM
Intravenous Immunoglobulin Market Size Worth USD 3...
Source: Sns Insider